The Kaplan–Meier analysis indicated that GBM patients with high expression of CARHSP1, KIAA0895, FBMIL1, and STRA6 exhibited worse overall survival as compared to patients with low expression of these genes (P = 0.0, P = 4e−04, P = 0.041, P = 2e−04, log-rank test, Fig. 2C). The gene discussed is STRA6; the disease is glioblastoma.